Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT02861898
What this trial is testing

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerBrain Neoplasm+4 more
Northwell Health 33
Early research (Phase 1)Study completedNCT01037738
What this trial is testing

Study of Autologous Conditioned Serum After Anterior Cruciate Ligament Reconstructive Surgery

Who this might be right for
Joint Instability
University of Zagreb 62
Not applicableStudy completedNCT01831648
What this trial is testing

Establishment of Reference Values for Insulin-like Growth Factor 1 (IGF1) in the General Population

Who this might be right for
Population
Assistance Publique - Hôpitaux de Paris 924
Large-scale testing (Phase 3)Study completedNCT00571727
What this trial is testing

Long-Term Treatment With rhIGF-1 in GHIS

Who this might be right for
Growth Hormone Insensitivity Syndrome
Ipsen 92
Early research (Phase 1)Study completedNCT00069446
What this trial is testing

A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers

Who this might be right for
Foot Ulcer
Genentech, Inc. 50
Not applicableActive Not RecruitingNCT03904173
What this trial is testing

Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHormone Receptor Positive Tumor
Oslo University Hospital 2,300
Not applicableAvailableNCT03620318
What this trial is testing

Individual Patient Compassionate Use of Crenolanib

Who this might be right for
FLT3-ITD MutationFLT3/TKD MutationPDGFR-Alpha D842V+1 more
Arog Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)UnknownNCT02067013
What this trial is testing

Analysis of Aqueous and Vitreous Humor

Who this might be right for
Proliferative Diabetic RetinopathyMacular DegenerationMacular Hole+1 more
California Retina Consultants 45
Testing effectiveness (Phase 2)Ended earlyNCT05221320
What this trial is testing

Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies

Who this might be right for
Tumor, SolidGastrointestinal Cancer
BioMed Valley Discoveries, Inc 47
Not applicableStudy completedNCT00475982
What this trial is testing

Effect of Weight Loss on Prostate Cancer Pathology

Who this might be right for
ObesityProstate Cancer
VA Office of Research and Development 44
Early research (Phase 1)Study completedNCT01288261
What this trial is testing

Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastMale Breast CancerRecurrent Breast Cancer+2 more
University of Arizona 14
Testing effectiveness (Phase 2)Study completedNCT02283554
What this trial is testing

Platelet Rich Fibrin With 1% Metformin Gel for Treatment of Intrabony Defects

Who this might be right for
Periodontitis
Government Dental College and Research Institute, Bangalore 120
Testing effectiveness (Phase 2)UnknownNCT00812513
What this trial is testing

Efficacy of R-Pdf/Gbb in Healing Wounds Caused by Third Degree Thermal and Electrical Burns

Who this might be right for
BurnsElectric Burns
American Scitech International 120
Early research (Phase 1)Study completedNCT01220570
What this trial is testing

The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 63
Testing effectiveness (Phase 2)Ended earlyNCT00679029
What this trial is testing

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

Who this might be right for
HER2-negative Breast CancerStage II Breast CancerStage IIIA Breast Cancer+2 more
University of Nebraska 15
Post-approval studies (Phase 4)UnknownNCT01857544
What this trial is testing

Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

Who this might be right for
Retinal Vein Occlusion
Tennessee Retina 10
Not applicableStudy completedNCT00641316
What this trial is testing

An Assessment of Bone Augmentation in Post-Extraction Sockets

Who this might be right for
Unrestorable DentitionPost-Extraction Sockets
University of Alabama at Birmingham 41
Not applicableUnknownNCT04240600
What this trial is testing

Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital Stay

Who this might be right for
Acute Myeloid Leukemia, Adult
Hospital General de Mexico 74
Early research (Phase 1)Looking for participantsNCT06415487
What this trial is testing

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Acepodia Biotech, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT03817567
What this trial is testing

Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sinocelltech Ltd. 50
Next Page